International Stem Cell Corporation
ISCO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9 | $8 | $8 | $7 |
| % Growth | 16.6% | -4.8% | 14% | – |
| Cost of Goods Sold | $4 | $3 | $3 | $3 |
| Gross Profit | $5 | $5 | $5 | $4 |
| % Margin | 58.6% | 59.2% | 60% | 59.1% |
| R&D Expenses | $1 | $1 | $0 | $1 |
| G&A Expenses | $4 | $4 | $3 | $4 |
| SG&A Expenses | $5 | $5 | $5 | $5 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $6 |
| Operating Income | -$0 | -$1 | -$0 | -$2 |
| % Margin | -0.7% | -8.5% | -2.4% | -26.8% |
| Other Income/Exp. Net | -$0 | $1 | -$0 | $1 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -2.3% | -1.7% | -5.7% | -14.5% |
| EPS | -0.026 | -0.016 | -0.058 | -0.13 |
| % Growth | -59.1% | 71.8% | 55.2% | – |
| EPS Diluted | -0.026 | -0.016 | -0.058 | -0.13 |
| Weighted Avg Shares Out | 8 | 8 | 8 | 8 |
| Weighted Avg Shares Out Dil | 8 | 8 | 8 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 1.6% | 2.6% | 0.3% | -3.1% |